Working together to find the best treatments, make them available, improve patient care and, ultimately, to find a cure for myeloma.
We help myeloma patients, their family and carers, by using your donations to develop new approaches to myeloma treatment through our biomedical research programme which includes translational research projects and the development of early phase clinical trials. We also use our Health Services Research Programme and patient advocacy to get patients the highest quality of care and access to the best treatments.
Patients are at the centre of everything we do. Find out how we are giving a voice to myeloma patients, pressing for access to new drug treatments and helping shape government policy.
Find out how our innovative approach to research and personalised patient treatment is helping us discover the causes of myeloma and how this can lead to the most effective types of treatment.
Our Health Service Research programme focusses on collecting evidence and answering questions to shape healthcare decisions which support patients having the best outcomes and quality of life.
Find out more about Clinical Trials and how we are supporting the development of new trials to ensure patients have access to new treatments and combinations
The Myeloma UK Research Advisory Group is our independent scientific group of experts who provide knowledge, input, guidance and expertise to the Research Programme.
You can also use our Ask the Nurse email service about any specific questions.
Support Myeloma UK: There are a number of ways you can support us and our work - take part in an event, makes one off donation or set up a monthly debit
